ISPOR Europe 2026
Panel
AI in HEOR: Advancing Evidence Generation for Joint Clinical Assessment
Mon, Nov 9, 2026 · 12:15–1:15 PM CET Hall L, Level 1, Austria Center Vienna
About this session
Artificial intelligence (AI) is rapidly transforming how health economics and outcomes research (HEOR) is conducted across the pharmaceutical industry. As the Joint Clinical Assessment (JCA) takes place across Europe under the EU Health Technology Assessment (HTA) Regulation, the potential for AI use has attracted interest among many HEOR researchers.
